Browse studies
Find your next paid study
40 recruiting studies matching your filters
Gastric Cancer Prevention: Understanding Precursor Lesions and Risk Factors for Progression to Cancer
The purpose of this study is to create a registry of participants with precursor lesions for gastric cancer, including gastric atrophy, intestinal metaplasia, …
Gastric AtrophyGastric Intestinal MetaplasiaDysplasia+2 more
Estimated
~$10 – $750
Memorial Sloan Kettering Cancer CenterNCT06370143
Phase 1
A Phase I Trial of Intraperitoneal Mesothelin-Targeted CAR T-Cell Therapy in Patients With Mesothelin-Positive Esophagogastric Adenocarcinoma With Peritoneal Carcinomatosis
Participants will have a sample of their white blood cells, called T cells, collected using a procedure called leukapheresis. The collected T cells will be sen…
Mesothelin PositiveMesothelin-Expressing TumorsEsophageal Adenocarcinoma+5 more
Estimated
~$10 – $6,250
Memorial Sloan Kettering Cancer CenterNCT06623396
Phase 1
A Phase 1, Multicenter, Open-label, Dose-escalation Study Evaluating the Safety and Tolerability of Intravenous KK2269 Monotherapy and Combination Therapy With Docetaxel in Adult Participants With Solid Tumors
This is a first-in-human study of KK2269. Part 1 and Part 2 will be conducted as a multicenter, open-label, non-randomized, dose-escalation study. Participants…
Advanced Solid TumorMetastatic Solid TumorGastric Adenocarcinoma+3 more
Estimated
~$10 – $8,750
Kyowa Kirin Co., Ltd.NCT06266299
Phase 2
A Phase 2 Randomized Study to Evaluate the Safety, Efficacy, and Optimal Dose of Telisotuzumab Adizutecan in Combination With Fluorouracil, Leucovorin, and Budigalimab as First-Line Treatment in Subjects With Locally Advanced Unresectable or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (AndroMETa-GEA-977)
Cancer is a condition where cells in a specific part of body grow and reproduce uncontrollably. The purpose of this study is to assess adverse events and chang…
Locally Advanced Unresectable or Metastatic Gastric AdenocarcinomaGastroesophageal Junction AdenocarcinomaEsophageal Adenocarcinoma
Estimated
~$10 – $7,500
AbbVieNCT06628310